SCHEMBL16261

SCHEMBL16261

CC(O)(c1ccc(N2CCN(S(=O)(=O)C3=CC=CCC3=S)C[C@H]2CN2CCOC[C@H]2CO)cc1)C(F)(F)F

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
GCK P35557 12/20 0.58
GCKR Q14397 8/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20769 1.00 GCK (0.58) GCKGCKR
SCHEMBL12078572 1.00 GCK (0.58) GCKGCKR
SCHEMBL12078893 1.00 GCK (0.58) GCKGCKR
SCHEMBL12078984 1.00 GCK (0.58) GCKGCKR
SCHEMBL16066 1.00 GCK (0.58) GCKGCKR
SCHEMBL12079347 1.00 GCK (0.58) GCKGCKR
SCHEMBL12078107 1.00 GCK (0.58) GCKGCKR
SCHEMBL12078992 1.00 GCK (0.58) GCKGCKR
SCHEMBL16535 1.00 GCK (0.58) GCKGCKR
SCHEMBL16845 1.00 GCK (0.58) GCKGCKR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed